Who was studied, and how
Two numbers in the abstract
Where each one falls
Where it lands on the map
1,269people with type 2 diabetes, in this paper
Among added to sulfonylurea, the trial randomly assignedassigned by chance
pioglitazone
metformin
Reported lower fasting FFAs, no range given−0.08
randomisedAmong added to metformin, the trial randomly assignedassigned by chance
pioglitazone
metformin
Reported lower fasting FFAs, no range given−0.11
randomisedthe abstract, start to end
… treatment decreased fasting FFAs by 0.08 mmol L(-1) when added to sulfonylurea and by 0.11 mmol L(-1) when added to …
← favours treatmentfavours comparator →
could be chanceNo interval given · direction only, strength unknown
Fasting FFAspioglitazone vs metformin, in added to sulfonylurea
−0.08
Fasting FFAspioglitazone vs metformin, in added to metformin
−0.11
ThiazolidinedionesGlycemic control
1 / 4